3. Nephros raises $3m in private placement
The 45¢-per-share deal was led by the Pessin family and included other accredited investors and Nephros management.
“We are pleased to take this opportunity to bolster our financial position,” president & CEO Daron Evans said in prepared remarks. “A stronger balance sheet will enable us to better manage our increasing inventory demands and to invest in our same-day delivery service for emergency responses to hospital infection outbreaks. In addition, Nephros now has the flexibility to support its next-generation HDF product line, to take advantage of strategic growth opportunities, and to explore a listing on a national exchange.”